Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Melanoma × Clear all

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03893019 2024-05-16

MB-CART20.1 Melanoma

Phase EARLY_PHASE1 Terminated

9 enrolled

Dermatologic

Melanoma

NCT04541108 2024-04-18

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Phase EARLY_PHASE1 Recruiting

15 enrolled

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT03655756 2022-08-08

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Phase EARLY_PHASE1 Completed

7 enrolled 9 charts

Dermatologic

Melanoma

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Phase EARLY_PHASE1 Withdrawn

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT03649529 2019-12-06

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Phase EARLY_PHASE1 Unknown

6 enrolled

Dermatologic

Melanoma

NCT03454243 2019-04-25

TITAN

Phase EARLY_PHASE1 Terminated

1 enrolled

DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

NCT02442466 2015-05-20

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

Phase EARLY_PHASE1 Terminated

5 enrolled

Dermatologic

Melanoma

NCT00743353 2009-02-02

K5

Phase EARLY_PHASE1 Completed

16 enrolled

BreastCNSDermatologicHead & NeckSarcomaThoracic

Astrocytoma, Breast Neoplasms, Glioblastoma, Laryngeal Diseases, Lung Neoplasms, Melanoma, Oligodendroglioma, Sarcoma

Clinical Trials

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

MB-CART20.1 Melanoma

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

TITAN

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

K5